Bartholomew R S
Trans Ophthalmol Soc U K (1962). 1978;98(4):482-5.
Implants with a regime of fibrosis suppression (prednisolone 30 mg daily plus fluphenamic acid 200 mg three times a day for 6 to 8 weeks) controlled the intraocular pressure (applanation tonometry (AT) less than 21 mm Hg) in seven out of ten patients with different types of glaucoma. One implant was removed after erosion of the conjunctiva and sclera; there were no other serious complications. Use of the implant is indicated after failed drainage operations or as a primary procedure in glaucoma associated with aphakia, chronic uveitis, vitreous in the anterior chamber, and scarring of the conjunctiva.
采用抑制纤维化方案(每日30毫克泼尼松龙加每日三次200毫克氟灭酸,持续6至8周)的植入物,在十名不同类型青光眼患者中,使七名患者的眼压得到控制(压平眼压计测量值低于21毫米汞柱)。一枚植入物在结膜和巩膜侵蚀后被取出;未出现其他严重并发症。在引流手术失败后,或作为与无晶状体、慢性葡萄膜炎、前房玻璃体以及结膜瘢痕相关的青光眼的初次手术时,可考虑使用该植入物。